Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $28.93M | $12.61M | +129.53% |
Operating Income | $-114M | $-111.96M | -1.83% |
Net Income | $-107.44M | $-103.13M | -4.18% |
EPS (Basic) | $-1.12 | $-1.17 | +4.27% |
EPS (Diluted) | $-1.12 | $-1.17 | +4.27% |
R&D Expense | $111.85M | $97.12M | +15.17% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $1.26B | $1.42B | -11.16% |
Current Assets | $884.04M | $963.67M | -8.26% |
Total Liabilities | $223.45M | — | — |
Current Liabilities | $97.91M | $103.38M | -5.29% |
Stockholders' Equity | $1.04B | $1.19B | -12.99% |
Cash & Equivalents | $171.98M | $294.15M | -41.53% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-120.66M | $-109.33M | -10.37% |
Investing Cash Flow | $5.9M | $-122.25M | +104.83% |
Financing Cash Flow | $59.99M | $2.22M | +2601.13% |
D&A | $2.51M | $2.05M | +22.54% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -394.0% | -888.1% | +494.14% |
Net Margin | -371.3% | — | — |
ROE | -10.4% | — | — |
ROA | -8.5% | — | — |
Current Ratio | $9.029 | — | — |
Debt to Equity | $0.216 | — | — |
Other companies in Biotechnology